Actively Recruiting

Phase Not Applicable
Age: 18Years - 25Years
FEMALE
ID07176910

Doppler Ultrasound-Guided Angiopuncture for Dysmenorrhea Pain: A Clinical Trial

Led by City University of Hong Kong · Updated on 2025-09-16

30

Participants Needed

1

Research Sites

4 weeks

Total Duration

On this page

Sponsors

C

City University of Hong Kong

Lead Sponsor

T

The Third Affiliated Hospital of Changchun University of Chinese Medicine

Collaborating Sponsor

AI-Summary

What this Trial Is About

This research aims to evaluate the effectiveness and safety of Doppler ultrasound-guided angiopuncture therapy in females experiencing dysmenorrhea, which is painful menstrual cramps. The study focuses on patients diagnosed with primary dysmenorrhea who have regular menstrual cycles and no pelvic pathology. The trial is interventional and sponsored by the City University of Hong Kong. Participants will receive angiopuncture therapy targeted at perforator points identified using Doppler ultrasound. The treatment involves guided angiopuncture focused on reducing menstrual pain. The study includes one treatment group receiving this therapy and monitors changes in pain levels before and after the intervention. During the study, participants' pain will be assessed using a visual analog scale at multiple time points: before treatment, immediately after treatment, and during three monthly follow-up visits over three months. Researchers will track pain changes and safety throughout this period. The total study duration includes these check-ups to evaluate lasting effects of the therapy.

CONDITIONS

Brief Title

Doppler Ultrasound-Guided Angiopuncture for Dysmenorrhea Pain: A Clinical Trial

Who Can Participate

Age: 18Years - 25Years
FEMALE

Eligibility Criteria

Eligible

You may qualify if you...

  • Female aged 18 to 25 years
  • Diagnosed with primary dysmenorrhea with at least 6 months of menstrual pain scoring 2 or higher on the numerical rating scale
  • Regular menstrual cycles lasting 28 to 32 days
  • Menstrual period duration of 4 to 7 days
  • No pelvic pathology detected by transvaginal ultrasound
Not Eligible

You will not qualify if you...

  • Coagulopathy with INR greater than 1.5
  • Recent use of analgesics within 48 hours before the study
  • Diagnosis of secondary dysmenorrhea confirmed by laparoscopy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Your Study Journey

Screening

Duration - 2 to 4 weeks

Participants are screened for eligibility to participate in the trial.

1 visit (in-person)

Treatment

Duration - Single session with follow-up assessments over 3 months

Participants undergo angiopuncture therapy guided by Doppler ultrasound on perforator points.

1 treatment visit and 3 monthly follow-up visits

Trial Site Locations

Total: 1 location

1

The Third Affiliated Hospital of Changchun University of Chinese Medicine

Changchun, China

Actively Recruiting

Loading map...

Research Team

R

Rong HAN, PhD student

Y

Yuenkei LEE, Mphil

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Similar Trials

Frequently Asked Questions

Have more questions? Get in touch with our team for quick support

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here